Sign Up to like & get
recommendations!
0
Published in 2019 at "European journal of medicinal chemistry"
DOI: 10.1016/j.ejmech.2018.11.074
Abstract: The Escherichia coli neutral M1-aminopeptidase (ePepN) is a novel target identified for the development of antimicrobials. Here we describe a solid-phase multicomponent approach which enabled the discovery of potent ePepN inhibitors. The on-resin protocol, developed…
read more here.
Keywords:
potent selective;
discovery potent;
escherichia coli;
aminopeptidase ... See more keywords